09:39 PM EDT, 08/24/2022 (MT Newswires) -- 3SBIO's (HKG:1530) first-half net profit attributable to owners rose 6.2% to 954.5 million yuan ($139.1 million) from 898.9 million yuan a year ago, according to a bourse filing on Wednesday.
Earnings per share inched up to 0.37 yuan from 0.34 yuan.
The pharmaceutical products company's revenue slid 0.5% to 3.09 billion yuan from 3.11 billion yuan, while gross profit inched down 0.9% to 2.57 billion yuan from 2.59 billion yuan.
3SBIO's board did not recommend any interim dividend.
Price (HKD): $5.11, Change: $+0.01, Percent Change: +0.20%